title: Risk factors and clinical expression of HCV infection in hemodialysis patients.
abstract: In our Dialytic Unit, the prevalence of antibodies to HCV (anti-HCV) was 16.4% in 1990 (73 hemodialyzed) and 21% in 1991 (105 hemodialyzed). The incidence of seroconversion was 13.1%. The transaminase behavior was similar in a group of anti-HCV-positive and a group of anti-HCV-negative patients and with previous HBV infection. Blood transfusions and dialytic age did not affect anti-HCV positivity.
authors.affiliation: Servizio di Virologia Ospedale Regionale Torrette, Ancona, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Pauri
authors.forename: G
authors.initials: G
authors.lastname: Salvoni
authors.forename: W
authors.initials: W
authors.lastname: Vitolo
authors.forename: P
authors.initials: P
authors.lastname: Carletti
authors.forename: E
authors.initials: E
authors.lastname: Fanciulli
authors.forename: A M
authors.initials: AM
authors.lastname: Ricciatti
authors.forename: S
authors.initials: S
authors.lastname: Della Bella
authors.forename: V A
authors.initials: VA
authors.lastname: Mioli
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood; D006526:Hepatitis C / Q000209:etiology* / Q000276:immunology / Q000635:transmission; D006801:Humans; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D065227:Transfusion Reaction
chemical_list: D006508:Hepatitis Antibodies; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase